Category: Telomerase

CBOs implementing quick HIV testing applications in nonclinical configurations should identify locations where they are able to best target individuals who have not previously been tested. people received fast HIV testing. From the 267 people (1.1%) with newly diagnosed HIV disease, 75% received their confirmatory test outcomes and 64% had been referred to treatment. Seventy-six…